Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences

February 22, 2001

Two Lots of Premarin® Recalled

Memphis, TN (SafetyAlerts) - The Food and Drug Administration (FDA) said today that McKesson HBOC  is recalling certain lots of PremarinÆ tablets because of manufacturerís dissolution failure.

This is the first public notice of this Class III recall issued by FDA.

a)PremarinÆ tablets (conjugated estrogens tablets), 1.25mg, 1,000 count. Recall #D-093-1.
b)PremarinÆ tablets (conjugated estrogens tablets), 2.5mg, 100 count bottles. Recall #D-094-1.

a) LOT NOS. 00344, Exp. Date: 08/03; and 01065, Exp. Date: 02/04;

b) LOT NOS. 00430, Exp. Date: 10/03.

Ayerst Laboratories, Div. Of Wyeth-Ayerst Pharmaceuticals, Inc., Rouses Point, NY. And Wyeth Pharmaceuticals Co., Guayama, Puerto Rico.

McKesson HBOC, Memphis, TN., by intranet on October 23, 2000 and December 13, 2000. Firm-initiated recall ongoing.

Ninety wholesalers within the United States.

a) Lot 00344: 1,198 bottles; Lot 01065: 2,388 bottles.
b) Lot 00430: 2,932 bottles.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafetyAlerts subscribers February 22, 2001.  For more information regarding the SafetyAlerts free email alert service please click here.

Selected Recent Recalls

Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

SafetyAlerts compiles comprehensive safety recall information for the United States. SafetyAlerts Newsletter is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.